Lisa Paborsky
Lisa Paborsky is an accomplished executive driving corporate strategy, business development and operations for early-stage biotech companies. She has experience in a broad range of therapeutic areas and has supported drug discovery and platform companies advancing small molecules, biologics and gene therapies.
Lisa is skilled in preparing pitch material for venture capital fundraising and for pharmaceutical and biotech partnerships. She has worked with many start-ups to build strong relationships with patient advocacy groups, rare disease foundations, KOLs, and academic collaborators. She has been responsible for establishing and growing functions such as program and alliance management and corporate communications.
Trained as a biochemist, Lisa started her career in drug discovery as a post-doc at Genentech and later transitioned into business development roles. As Senior Vice President of Corporate Development and Strategic Relations at Mitobridge, Lisa helped launch the company and negotiated the successful “build to buy” option deal with Astellas Pharma.
Lisa earned a BS in biochemistry from SUNY Binghamton, a PhD in cancer biology from Stanford University.